198760-31-5 Usage
Uses
Used in Pharmaceutical Industry:
(5Z,7E,22E)-(1S,3R,24R)-25-(5-butyloxazole-2-yl)-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol is used as a potential therapeutic agent for [application reason] due to its unique structure and functional groups that may play a role in biological processes.
Used in Research and Development:
In the field of research and development, (5Z,7E,22E)-(1S,3R,24R)-25-(5-butyloxazole-2-yl)-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol is used as a subject for studying [application reason], such as its interaction with cellular receptors, potential effects on cellular signaling pathways, or its role in membrane function.
Check Digit Verification of cas no
The CAS Registry Mumber 198760-31-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,8,7,6 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 198760-31:
(8*1)+(7*9)+(6*8)+(5*7)+(4*6)+(3*0)+(2*3)+(1*1)=185
185 % 10 = 5
So 198760-31-5 is a valid CAS Registry Number.
198760-31-5Relevant academic research and scientific papers
Practical synthesis of a heterocyclic immunosuppressive vitamin D analogue
Westermann, Juergen,Schneider, Matthias,Platzek, Johannes,Petrov, Orlin
, p. 200 - 205 (2012/12/26)
1α,25-Dlhydroxyvitamin D3 (calcitrioi) 1 and synthetic analogues thereof are highly potent compounds with a wide range of pharmacological activity making them of great interest for the pharmaceutical industry. Herein we report an improved synthesis of the calcitriol analogue 2, which features a novel oxazole-containing side chain. The crucial part of the synthesis was the development of a practical route to the β-keto phosphonate 28, allowing an easy introduction of the unnatural side chain by a Wittig Horner reaction.
NEW VITAMIN D DERIVATIVES WITH CARBO-OR HETEROCYCLIC SUBSTITUENTS AT C-25, A PROCESS FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS AND THEIR USE FOR PRODUCING MEDICAMENTS
-
, (2008/06/13)
The invention concerns new vitamin D derivatives of general formula (I) a process for their production, their use for production of medicaments, and intermediate products used in the process.